Effect of selol on the opioids activity in streptozotocin induced hyperalgesia

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 6, 2008, Pages 691-696

  Bujalska, Magdalena ^a   Winecka, Renata ^a   Gumułka, Stanisław W ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Hyperalgesia; Opioids; Rats; Selol; Streptozotocin

Indexed keywords

ANTIOXIDANT; BUPRENORPHINE; FENTANYL; MORPHINE SULFATE; SELOL; STREPTOZOCIN; UNCLASSIFIED DRUG; MORPHINE; NARCOTIC ANALGESIC AGENT; SELENIUM DERIVATIVE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG POTENTIATION; HYPERALGESIA; HYPERGLYCEMIA; MALE; MECHANICAL STIMULATION; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; RAT; ANIMAL; DRUG COMBINATION; EXPERIMENTAL DIABETES MELLITUS; PAIN ASSESSMENT; PATHOPHYSIOLOGY; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; ANTIOXIDANTS; BUPRENORPHINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FENTANYL; HYPERALGESIA; MALE; MORPHINE; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, WISTAR; SELENIUM COMPOUNDS; STREPTOZOCIN;

EID: 61549136060     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Chung J.M.: Mol. Interv. 4, 248 (2004).
2. Khalil Z., Liu T., Helme R.D.: Pain 79, 31 (1999).
3. Gazda L.S., Milligan E.D., Hansen M.K., et al.: Peripher. Nerv. Syst. 6, 111 (2001).
4. Dyck P.J., Larson T.S., OíBrien P.C., Velosa J.A.: Diabetes Care 23, 510 (2000).
5. Hong S., Wiley J.W.: J. Biol. Chem. 280, 618 (2005).
6. Hong S., Morrow T.J., Paulson P.E., Isom L.L., Wiley J.W.: J. Biol. Chem. 279, 29341 (2004).
7. Suzuki Y., Sato J., Kawanishi M., Mizumura K.: Neurosci. Res. 43, 171 (2002).
8. Dobretsov M., Hastings S.L., Romanovsky D., Stimers J.R., Zhang J.M.: Brain Res. 960, 174 (2003).
9. Romanovsky D., Hastings S.L., Stimers J.R., Dobretsov M.: J. Peripher. Nerv. Syst. 9, 62 (2004).
10. Cameron N.E., Tuck Z., McCabe L., Cotter M.A.: Diabetologia 44, 1161 (2001).
11. Cotter M.A., Love A., Watt M.J., Cameron N.E., Dines K.C.: Diabetologia 38, 1285 (1995).
12. Koller L.D., Exon J.H.: Can. J. Vet. Res. 50, 297 (1986).
13. Prabhu K.S., Zamamiri-Davis F., Stewart J.B., Thompson J.T., Sordillo L.M., Reddy C.C.: Biochem. J. 366, 203 (2002).
14. Suchocki P., Jakoniuk D., Fitak B.A.: J. Pharm. Biomed. Anal. 32, 1029 (2003).
15. Suchocki P.: farm.amwaw.edu.pl/authority/SELOL.pdf, (2007).
16. Jastrzȩbski Z., Czyżewska-Szafran H., Fijałek Z., Suchocki P., Fitak B.A.: Drugs Exptl. Clin. Res. 21, 217 (1995).
17. Jastrzȩbski Z., Czyżewska-Szafran H., Remiszewska M., Fijatek Z., Fitak B.A., Suchocki P.: Drugs Exptl. Clin. Res. 23, 7 (1997).
18. Nakhoda A., Wong H.A.: Experientia 35, 1679 (1979).
19. Randall L.O., Selitto J.J.: Arch. Int. Pharmacodyn. Ther. 111, 409 (1957).
20. nd ed., p. 113-117, Springer, New York 1986.
21. Aley K.O., Levine J.D.: Neuroscience 111, 389 (2002).
22. Uzel N., Sivas A., Uysal M., Oz H.: Horm. Metabol. Res. 19, 89 (1987).
23. Wagner R., Heckman H.M., Myers R.R.: Pain 77, 173 (1998).
24. Rokyta R., Holecek V., Pekárková I., Krejcová J., Racek J., Trefil L., Yamamotová A.: Neuroendocrinol. Lett. 24, 304 (2003).
25. Raghavendra V., Tanga F., Rutkowski M.D., DeLeo J.A.: Pain 104, 655 (2003).
26. Savegnago L., Jesse C.R., Moro A.V., Borges V.C., Santos F.W., Rocha J.B., Nogueira C.W.: Pharmacol. Biochem. Behav. 83, 221 (2006).
27. Nogueira C.W., Quinhones E.B., Jung E.A., Zeni G., Roch J.B.: Inflamm. Res. 52, 56 (2003).
28. Courteix C., Bardin M., Chantelauze C., Laverenne J., Eschalier A.: Pain 57, 153 (1994).
29. Zurek J.R., Nadeson R., Goodchild C.S.: Pain 90, 57 (2001).
30. Raz I., Hasdai D., Seltzer Z., Melmed R.N.: Diabetes 37, 1253 (1998).
31. Ulugol A., Aslantas A., Tuncer A., Hakan C., Dokmeci I.: Brain Res. 943, 101 (2002).
32. Grover S., Sharma A., Singh M.: Eur. J. Pharm. 399, 161 (2000).
33. Xiangqi L., Clark D.: Mol. Brain Res. 95, 96 (2001).
34. Kim S.H., Johnson V.J., Tae-Yong S., Sharma R.P.: Exp. Biol. Med. 299, 203 (2004).
35. Yun Ch.-H., Yang J.S., Kang S., Yang Y., Cho J.H., Son C.G., Han S.H.: Int. Immunopharmacol. 7, 1192 (2007).
36. Suchocki P., Misiewicz I., Skupińska K., Wacławek K., Fijałek Z., Skrzycka-Gutman T.: Oncol. Rep. 18, 893 (2007).